209 related articles for article (PubMed ID: 30426268)
1. The post hoc analysis comparing the severity grades of chemoradiotherapy-induced oral mucositis scored between the central and local assessors in a multicenter, randomized controlled trial of rebamipide for head and neck cancer.
Ueno T; Zenda S; Konishi T; Yurikusa T; Shibasaki Y; Nagamoto H; Fujii M
Int J Clin Oncol; 2019 Mar; 24(3):241-247. PubMed ID: 30426268
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II study.
Yokota T; Ogawa T; Takahashi S; Okami K; Fujii T; Tanaka K; Iwae S; Ota I; Ueda T; Monden N; Matsuura K; Kojima H; Ueda S; Sasaki K; Fujimoto Y; Hasegawa Y; Beppu T; Nishimori H; Hirano S; Naka Y; Matsushima Y; Fujii M; Tahara M
BMC Cancer; 2017 May; 17(1):314. PubMed ID: 28476132
[TBL] [Abstract][Full Text] [Related]
3. Rebamipide gargle in preventive management of chemo-radiotherapy induced oral mucositis.
Chaitanya B; Pai KM; Yathiraj PH; Fernandes D; Chhaparwal Y
Oral Oncol; 2017 Sep; 72():179-182. PubMed ID: 28797456
[TBL] [Abstract][Full Text] [Related]
4. Rebamipide gargle and benzydamine gargle in prevention and management of chemo-radiotherapy and radiotherapy-induced oral mucositis in head and neck cancer patients (randomized clinical trial).
Elsaadany B; Anayb SM; Mashhour K; Yossif M; Zahran F
BMC Oral Health; 2024 Jun; 24(1):645. PubMed ID: 38824583
[TBL] [Abstract][Full Text] [Related]
5. Confounding factors associated with oral mucositis assessment in patients receiving chemoradiotherapy for head and neck cancer.
Chung YL; Pui NNM
Support Care Cancer; 2017 Sep; 25(9):2743-2751. PubMed ID: 28353040
[TBL] [Abstract][Full Text] [Related]
6. The effectiveness of Zataria extract mouthwash for the management of radiation-induced oral mucositis in patients: a randomized placebo-controlled double-blind study.
Aghamohammadi A; Moslemi D; Akbari J; Ghasemi A; Azadbakht M; Asgharpour A; Hosseinimehr SJ
Clin Oral Investig; 2018 Jul; 22(6):2263-2272. PubMed ID: 29313134
[TBL] [Abstract][Full Text] [Related]
7. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.
Mantovani G; Massa E; Astara G; Murgia V; Gramignano G; Lusso MR; Camboni P; Ferreli L; Mocci M; Perboni S; Mura L; Madeddu C; Macciò A
Oncol Rep; 2003; 10(1):197-206. PubMed ID: 12469169
[TBL] [Abstract][Full Text] [Related]
8. The effectiveness of rebamipide mouthwash therapy for radiotherapy and chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a systematic review and meta-analysis.
Akagi S; Fujiwara T; Nishida M; Okuda A; Nagao Y; Okuda T; Tokuda H; Takayanagi K
J Pharm Health Care Sci; 2019; 5():16. PubMed ID: 31367460
[TBL] [Abstract][Full Text] [Related]
9. [Investigation of how to prevent mucositis induced by chemoradiotherapy].
Tosaka C; Tajima H; Inoue T; Moya M; Kobayashi M; Miura K; Tada Y; Masubuchi T; Hushimi C; Kamata S
Gan To Kagaku Ryoho; 2011 Oct; 38(10):1647-51. PubMed ID: 21996960
[TBL] [Abstract][Full Text] [Related]
10. Phenylbutyrate mouthwash mitigates oral mucositis during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer.
Yen SH; Wang LW; Lin YH; Jen YM; Chung YL
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1463-70. PubMed ID: 21840136
[TBL] [Abstract][Full Text] [Related]
11. Double-blind randomized phase III study comparing a mixture of natural agents versus placebo in the prevention of acute mucositis during chemoradiotherapy for head and neck cancer.
Marucci L; Farneti A; Di Ridolfi P; Pinnaro P; Pellini R; Giannarelli D; Vici P; Conte M; Landoni V; Sanguineti G
Head Neck; 2017 Sep; 39(9):1761-1769. PubMed ID: 28560780
[TBL] [Abstract][Full Text] [Related]
12. Multicenter phase II study of an oral care program for patients with head and neck cancer receiving chemoradiotherapy.
Yokota T; Tachibana H; Konishi T; Yurikusa T; Hamauchi S; Sakai K; Nishikawa M; Suzuki M; Naganawa Y; Hagihara T; Tsumaki H; Kubo T; Sato M; Taguri M; Morita S; Eguchi T; Kubota K; Zenda S
Support Care Cancer; 2016 Jul; 24(7):3029-36. PubMed ID: 26887378
[TBL] [Abstract][Full Text] [Related]
13. Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study.
Gouvêa de Lima A; Villar RC; de Castro G; Antequera R; Gil E; Rosalmeida MC; Federico MH; Snitcovsky IM
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):270-5. PubMed ID: 21163585
[TBL] [Abstract][Full Text] [Related]
14. L-glutamine decreases the severity of mucositis induced by chemoradiotherapy in patients with locally advanced head and neck cancer: a double-blind, randomized, placebo-controlled trial.
Tsujimoto T; Yamamoto Y; Wasa M; Takenaka Y; Nakahara S; Takagi T; Tsugane M; Hayashi N; Maeda K; Inohara H; Uejima E; Ito T
Oncol Rep; 2015 Jan; 33(1):33-9. PubMed ID: 25351453
[TBL] [Abstract][Full Text] [Related]
15. Multi-institutional, randomized, double-blind, placebo-controlled trial to assess the efficacy of a mucoadhesive hydrogel (MuGard) in mitigating oral mucositis symptoms in patients being treated with chemoradiation therapy for cancers of the head and neck.
Allison RR; Ambrad AA; Arshoun Y; Carmel RJ; Ciuba DF; Feldman E; Finkelstein SE; Gandhavadi R; Heron DE; Lane SC; Longo JM; Meakin C; Papadopoulos D; Pruitt DE; Steinbrenner LM; Taylor MA; Wisbeck WM; Yuh GE; Nowotnik DP; Sonis ST
Cancer; 2014 May; 120(9):1433-40. PubMed ID: 24877167
[TBL] [Abstract][Full Text] [Related]
16. Effect of photobiomodulation on the severity of oral mucositis and molecular changes in head and neck cancer patients undergoing radiotherapy: a study protocol for a cost-effectiveness randomized clinical trial.
Martins AFL; Nogueira TE; Morais MO; Oton-Leite AF; Valadares MC; Batista AC; Freitas NMA; Leles CR; Mendonça EF
Trials; 2019 Feb; 20(1):97. PubMed ID: 30709370
[TBL] [Abstract][Full Text] [Related]
17. Beneficial Effects of Adjuvant Melatonin in Minimizing Oral Mucositis Complications in Head and Neck Cancer Patients Receiving Concurrent Chemoradiation.
Onseng K; Johns NP; Khuayjarernpanishk T; Subongkot S; Priprem A; Hurst C; Johns J
J Altern Complement Med; 2017 Dec; 23(12):957-963. PubMed ID: 28657801
[TBL] [Abstract][Full Text] [Related]
18. The Indian Spice Turmeric Delays and Mitigates Radiation-Induced Oral Mucositis in Patients Undergoing Treatment for Head and Neck Cancer: An Investigational Study.
Rao S; Dinkar C; Vaishnav LK; Rao P; Rai MP; Fayad R; Baliga MS
Integr Cancer Ther; 2014 May; 13(3):201-10. PubMed ID: 24165896
[TBL] [Abstract][Full Text] [Related]
19. Low-level laser therapy in treatment of chemoradiotherapy-induced mucositis in head and neck cancer: results of a randomised, triple blind, multicentre phase III trial.
Legouté F; Bensadoun RJ; Seegers V; Pointreau Y; Caron D; Lang P; Prévost A; Martin L; Schick U; Morvant B; Capitain O; Calais G; Jadaud E
Radiat Oncol; 2019 May; 14(1):83. PubMed ID: 31118057
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effect of recombinant human epidermal growth factor (RhEGF) on mucositis in patients undergoing radiotherapy, with or without chemotherapy, for head and neck cancer: a double-blind placebo-controlled prospective phase 2 multi-institutional clinical trial.
Wu HG; Song SY; Kim YS; Oh YT; Lee CG; Keum KC; Ahn YC; Lee SW
Cancer; 2009 Aug; 115(16):3699-708. PubMed ID: 19514089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
